234 related articles for article (PubMed ID: 20184741)
1. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
[TBL] [Abstract][Full Text] [Related]
2. Identification of 5 novel genes methylated in breast and other epithelial cancers.
Hill VK; Hesson LB; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins T; Gentle D; Euhus D; Lewis C; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Mar; 9():51. PubMed ID: 20205715
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic analysis of childhood acute lymphoblastic leukemia.
Dunwell TL; Hesson LB; Pavlova T; Zabarovska V; Kashuba V; Catchpoole D; Chiaramonte R; Brini AT; Griffiths M; Maher ER; Zabarovsky E; Latif F
Epigenetics; 2009 Apr; 4(3):185-93. PubMed ID: 19430199
[TBL] [Abstract][Full Text] [Related]
4. Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia.
Borssén M; Palmqvist L; Karrman K; Abrahamsson J; Behrendtz M; Heldrup J; Forestier E; Roos G; Degerman S
PLoS One; 2013; 8(6):e65373. PubMed ID: 23762353
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukemia displays a distinct highly methylated genome.
Hetzel S; Mattei AL; Kretzmer H; Qu C; Chen X; Fan Y; Wu G; Roberts KG; Luger S; Litzow M; Rowe J; Paietta E; Stock W; Mardis ER; Wilson RK; Downing JR; Mullighan CG; Meissner A
Nat Cancer; 2022 Jun; 3(6):768-782. PubMed ID: 35590059
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
7. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
[TBL] [Abstract][Full Text] [Related]
8. ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.
Asimakopoulos FA; Shteper PJ; Krichevsky S; Fibach E; Polliack A; Rachmilewitz E; Ben-Neriah Y; Ben-Yehuda D
Blood; 1999 Oct; 94(7):2452-60. PubMed ID: 10498618
[TBL] [Abstract][Full Text] [Related]
9. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
[TBL] [Abstract][Full Text] [Related]
10. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
11. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia.
Almamun M; Levinson BT; van Swaay AC; Johnson NT; McKay SD; Arthur GL; Davis JW; Taylor KH
Epigenetics; 2015; 10(9):882-90. PubMed ID: 26308964
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
13. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34
Maupetit-Mehouas S; Court F; Bourgne C; Guerci-Bresler A; Cony-Makhoul P; Johnson H; Etienne G; Rousselot P; Guyotat D; Janel A; Hermet E; Saugues S; Berger J; Arnaud P; Berger MG
Mol Oncol; 2018 Jun; 12(6):814-829. PubMed ID: 29575763
[TBL] [Abstract][Full Text] [Related]
15. T-cell blast crisis of chronic myelogenous leukemia presented with coexisting p210 and p190 BCR-ABL transcripts and t(10;11)(q11;p15).
Xia T; Yang Y; Li G; Chang J; Li J; Ren F; Ren W; Wang H; Xu Z
J Clin Lab Anal; 2020 Jun; 34(6):e23241. PubMed ID: 32052899
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3.
Yang MY; Chang JG; Lin PM; Tang KP; Chen YH; Lin HY; Liu TC; Hsiao HH; Liu YC; Lin SF
Cancer Sci; 2006 Dec; 97(12):1298-307. PubMed ID: 16999817
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
20. Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?
Vatanmakanian M; Tavallaie M; Ghadami S
Cell Commun Signal; 2019 Apr; 17(1):38. PubMed ID: 31014357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]